Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin. [electronic resource]
Producer: 20161213Description: 227-31 p. digitalISSN:- 1365-2893
- Adult
- Aged
- Aminoisobutyric Acids
- Antiviral Agents -- administration & dosage
- Female
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- administration & dosage
- Leucine -- analogs & derivatives
- Male
- Middle Aged
- Oligopeptides -- administration & dosage
- Placebos -- administration & dosage
- Proline -- analogs & derivatives
- Quinolines
- Ribavirin -- administration & dosage
- Salvage Therapy -- methods
- Thiazoles -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.